US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Caribou Biosciences

1.93

-0.0300-1.53%

Post-market: 1.940.0100+0.52%19:58 EDT

Volume:821.30K

Turnover:1.59M

Market Cap:186.51M

PE:-1.21

High:1.98

Open:1.96

Low:1.90

Close:1.96

52wk High:3.54

52wk Low:0.7100

Shares:96.64M

Float Shares:87.57M

Volume Ratio:0.88

T/O Rate:0.94%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5900

EPS(LYR):-1.5900

ROE:-78.97%

ROA:-34.26%

PB:1.53

PE(LYR):-1.21

Loading ...

Overview Company News Filings

Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.

Caribou Biosciences to Participate in Upcoming Investor Conferences

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

Caribou Biosciences Is Maintained at Buy by Citigroup

ADVISORY-Alert inadvertently tagged to Caribou Biosciences withdrawn

Caribou Biosciences price target raised to $8 from $5 at Citi

Caribou Shares Surge On Positive Data From Two Drug Studies

Caribou Launches "Today's Auto Refinance Rates", First-Ever Daily Rates Resource Bringing Unmatched Transparency to What Lenders Are Actually Offering Borrowers

THOMSON REUTERS

Caribou Says Potential Non-Hodgkin Lymphoma Therapy Shows High Overall Response; Shares Rise Pre-Bell

MT Newswires Live

Top Premarket Gainers

MT Newswires Live

BRIEF-Caribou Biosciences Expects Cash And Marketable Securities As Of Sept 30 To Be $159.2 Million

Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel

Caribou Biosciences Inc - Expects Cash and Marketable Securities as of Sept 30, 2025 to Be $159.2 Mln - SEC Filing

THOMSON REUTERS

Caribou Biosciences Announces Positive Phase 1 Results for Vispa-cel in Relapsed or Refractory B Cell Lymphoma

Caribou Biosciences Inc - Vispa-Cel Well-Tolerated for Outpatient Administration

THOMSON REUTERS

Caribou Biosciences Announces Positive Data From Antler Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-Cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par With Autologous CAR-T Cell Therapies

THOMSON REUTERS

Caribou Biosciences Inc - 450 Mln Cell Dose Recommended for Expansion; Dose Expansion to Initiate by Year End, Data Expected 2026

THOMSON REUTERS

Caribou Biosciences Announces Positive Data From Cammouflage Phase 1 Trial of CB-011 in Multiple Myeloma

THOMSON REUTERS

Caribou Biosciences Inc - CB-011 Shows Manageable Safety Profile With No Gvhd Cases

THOMSON REUTERS

Caribou Biosciences Announces New Data from Phase 1 CAR-T Trials in Lymphoma and Multiple Myeloma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CRBU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRBU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRBU\",,,,,undefined,":{"symbol":"CRBU","market":"US","secType":"STK","nameCN":"Caribou Biosciences","latestPrice":1.93,"timestamp":1775851200000,"preClose":1.96,"halted":0,"volume":821295,"hourTrading":{"tag":"盘后","latestPrice":1.94,"preClose":1.93,"latestTime":"19:58 EDT","volume":281149,"amount":542678.3664,"timestamp":1775865508211,"change":0.01,"changeRate":0.005181,"amplitude":0.015544},"delay":0,"changeRate":-0.015306122448979605,"floatShares":87570600,"shares":96637202,"eps":-1.59,"marketStatus":"Market Closed","change":-0.03,"latestTime":"04-10 16:00:00 EDT","open":1.96,"high":1.9825,"low":1.9,"amount":1585812.6447075,"amplitude":0.042092,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.59,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776067200000},"marketStatusCode":7,"adr":0,"listingDate":1627012800000,"exchange":"NASDAQ","adjPreClose":1.96,"preHourTrading":{"tag":"盘前","latestPrice":1.96,"preClose":1.96,"latestTime":"09:25 EDT","volume":531,"amount":1048.5275742,"timestamp":1775827500002,"change":0,"changeRate":0,"amplitude":0.020408},"postHourTrading":{"tag":"盘后","latestPrice":1.94,"preClose":1.93,"latestTime":"19:58 EDT","volume":281149,"amount":542678.3664,"timestamp":1775865508211,"change":0.01,"changeRate":0.005181,"amplitude":0.015544},"volumeRatio":0.8798279767550545,"impliedVol":0.7416,"impliedVolPercentile":0.204},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRBU\",,,,,undefined,":{"symbol":"CRBU","floatShares":87570600,"roa":"-34.26%","roe":"-78.97%","lyrEps":-1.59,"volumeRatio":0.8798279767550545,"shares":96637202,"dividePrice":0,"high":1.9825,"amplitude":0.042092,"preClose":1.96,"low":1.9,"week52Low":0.71,"pbRate":"1.53","psRate":"16.71","week52High":3.535,"institutionHeld":0,"latestPrice":1.93,"eps":-1.59,"divideRate":0,"volume":821295,"delay":0,"ttmEps":-1.59,"open":1.96,"prevYearClose":1.59,"prevWeekClose":1.94,"prevMonthClose":1.9,"prevQuarterClose":1.9,"fiveDayClose":1.94,"twentyDayClose":1.89,"sixtyDayClose":1.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRBU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"CRBU","fiscalQuarterEnding":"2025/12","expectedEps":-0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-11-12","symbol":"CRBU","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.3},{"market":"US","date":"2025-08-12","symbol":"CRBU","fiscalQuarterEnding":"2025/06","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2025-05-08","symbol":"CRBU","fiscalQuarterEnding":"2025/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2022-02-08","symbol":"CRBU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1644296400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRBU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRBU\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1770091200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRBU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRBU","date":"2026-04-10","current":-1.213836,"percent":0.735672,"low":-44.022002,"twenty":-7.188294,"median":-3.422165,"eighty":-1.123922,"high":-0.457273,"avg":-5.826201,"sd":7.661595,"marketCap":189408915},"quantilePoints":[{"date":"2021-07-23","current":-24.57042,"twenty":-23.775494,"median":-22.583106,"eighty":-21.268958,"marketCap":925493997},{"date":"2021-07-30","current":-24.389755,"twenty":-24.498154,"median":-23.907982,"eighty":-23.034768,"marketCap":918688894},{"date":"2021-08-06","current":-33.70905,"twenty":-26.849808,"median":-24.57042,"eighty":-23.742373,"marketCap":1269718786},{"date":"2021-08-13","current":-36.479244,"twenty":-35.877028,"median":-26.128654,"eighty":-23.883893,"marketCap":1374063697},{"date":"2021-08-20","current":-39.27955,"twenty":-38.876065,"median":-32.670227,"eighty":-24.172957,"marketCap":1479542793},{"date":"2021-08-27","current":-40.619481,"twenty":-40.664647,"median":-35.726474,"eighty":-24.462021,"marketCap":1530013973},{"date":"2021-09-03","current":-35.882447,"twenty":-40.664647,"median":-36.479244,"eighty":-24.829373,"marketCap":1797925873},{"date":"2021-09-10","current":-34.529973,"twenty":-40.619481,"median":-35.882447,"eighty":-25.353301,"marketCap":1730158820},{"date":"2021-09-17","current":-29.407329,"twenty":-40.468927,"median":-34.697536,"eighty":-25.988639,"marketCap":1473483612},{"date":"2021-09-24","current":-29.012358,"twenty":-39.761322,"median":-34.099096,"eighty":-26.524611,"marketCap":1453693234},{"date":"2021-10-01","current":-26.702381,"twenty":-39.327727,"median":-33.413353,"eighty":-26.796906,"marketCap":1337949507},{"date":"2021-10-08","current":-22.932211,"twenty":-39.077807,"median":-32.97403,"eighty":-26.577906,"marketCap":1149041351},{"date":"2021-10-15","current":-24.942968,"twenty":-38.255782,"median":-30.556333,"eighty":-25.353301,"marketCap":1249792368},{"date":"2021-10-22","current":-24.775405,"twenty":-37.957685,"median":-29.072202,"eighty":-24.61263,"marketCap":1241396450},{"date":"2021-10-29","current":-26.463005,"twenty":-36.921874,"median":-28.778967,"eighty":-24.794555,"marketCap":1325955338},{"date":"2021-11-05","current":-26.857975,"twenty":-36.563554,"median":-28.485732,"eighty":-24.885518,"marketCap":1345745716},{"date":"2021-11-12","current":-20.684557,"twenty":-36.434091,"median":-27.773589,"eighty":-24.570723,"marketCap":1306167723},{"date":"2021-11-19","current":-20.284211,"twenty":-36.179273,"median":-27.396571,"eighty":-23.984482,"marketCap":1280887058},{"date":"2021-11-26","current":-16.852671,"twenty":-35.882447,"median":-27.175005,"eighty":-23.712262,"marketCap":1064195638},{"date":"2021-12-03","current":-16.271216,"twenty":-34.973704,"median":-26.953726,"eighty":-22.583106,"marketCap":1027478481},{"date":"2021-12-10","current":-16.623902,"twenty":-34.865099,"median":-26.702381,"eighty":-20.522512,"marketCap":1049749543},{"date":"2021-12-17","current":-15.060645,"twenty":-34.529973,"median":-26.552771,"eighty":-19.779012,"marketCap":951034563},{"date":"2021-12-23","current":-15.413331,"twenty":-34.520398,"median":-26.463005,"eighty":-17.962203,"marketCap":973305626},{"date":"2021-12-31","current":-14.383869,"twenty":-34.182878,"median":-26.259536,"eighty":-17.13482,"marketCap":908298200},{"date":"2022-01-07","current":-12.401202,"twenty":-33.936321,"median":-25.556548,"eighty":-16.745912,"marketCap":783098713},{"date":"2022-01-14","current":-11.066715,"twenty":-33.746365,"median":-24.871155,"eighty":-16.229275,"marketCap":698829828},{"date":"2022-01-21","current":-9.779887,"twenty":-33.354213,"median":-24.571936,"eighty":-15.954752,"marketCap":617570545},{"date":"2022-01-28","current":-9.827548,"twenty":-33.081749,"median":-24.271392,"eighty":-15.066364,"marketCap":620580148},{"date":"2022-02-04","current":-10.166322,"twenty":-33.007542,"median":-23.973496,"eighty":-14.595481,"marketCap":641972750},{"date":"2022-02-11","current":-10.271822,"twenty":-32.791748,"median":-23.7499,"eighty":-14.078844,"marketCap":648634731},{"date":"2022-02-18","current":-9.59087,"twenty":-32.091293,"median":-23.13568,"eighty":-12.378325,"marketCap":605634670},{"date":"2022-02-25","current":-9.466189,"twenty":-30.786134,"median":-22.583106,"eighty":-12.202035,"marketCap":597761419},{"date":"2022-03-04","current":-8.564647,"twenty":-29.297216,"median":-20.698855,"eighty":-11.154182,"marketCap":540831760},{"date":"2022-03-11","current":-8.81401,"twenty":-29.108108,"median":-20.39286,"eighty":-10.841818,"marketCap":556578261},{"date":"2022-03-18","current":-9.37028,"twenty":-29.048264,"median":-19.974419,"eighty":-10.440625,"marketCap":591705072},{"date":"2022-03-25","current":-8.357638,"twenty":-28.926183,"median":-19.559775,"eighty":-10.199298,"marketCap":559318216},{"date":"2022-04-01","current":-8.357638,"twenty":-28.782558,"median":-17.891665,"eighty":-9.98006,"marketCap":559318216},{"date":"2022-04-08","current":-7.487429,"twenty":-28.684414,"median":-17.167229,"eighty":-9.7837,"marketCap":501081179},{"date":"2022-04-14","current":-7.378652,"twenty":-28.552757,"median":-16.852671,"eighty":-9.575524,"marketCap":493801549},{"date":"2022-04-22","current":-7.061388,"twenty":-28.418707,"median":-16.700159,"eighty":-9.362607,"marketCap":472569295},{"date":"2022-04-29","current":-6.707866,"twenty":-28.088367,"median":-16.261684,"eighty":-9.086598,"marketCap":448910499},{"date":"2022-05-06","current":-6.644413,"twenty":-27.813086,"median":-16.133001,"eighty":-8.846618,"marketCap":444664048},{"date":"2022-05-13","current":-7.474433,"twenty":-27.698185,"median":-15.737421,"eighty":-8.680583,"marketCap":544527357},{"date":"2022-05-20","current":-6.899476,"twenty":-27.607222,"median":-15.084475,"eighty":-8.503265,"marketCap":502640637},{"date":"2022-05-27","current":-7.124459,"twenty":-27.372633,"median":-14.908132,"eighty":-8.363077,"marketCap":519031093},{"date":"2022-06-03","current":-7.28278,"twenty":-27.276883,"median":-14.603107,"eighty":-8.30325,"marketCap":530565117},{"date":"2022-06-10","current":-5.782894,"twenty":-27.175005,"median":-14.417231,"eighty":-8.075513,"marketCap":421295413},{"date":"2022-06-17","current":-4.624649,"twenty":-27.049476,"median":-13.907267,"eighty":-7.559946,"marketCap":336914920},{"date":"2022-06-24","current":-4.882963,"twenty":-27.039901,"median":-12.772952,"eighty":-7.48483,"marketCap":355733591},{"date":"2022-07-01","current":-4.449662,"twenty":-26.903457,"median":-12.29635,"eighty":-7.429197,"marketCap":324166787},{"date":"2022-07-08","current":-5.657904,"twenty":-26.862763,"median":-12.205044,"eighty":-7.276114,"marketCap":412189604},{"date":"2022-07-15","current":-5.966214,"twenty":-26.764619,"median":-11.499453,"eighty":-7.193733,"marketCap":434650599},{"date":"2022-07-22","current":-6.291189,"twenty":-26.6952,"median":-11.100798,"eighty":-7.102857,"marketCap":458325702},{"date":"2022-07-29","current":-6.766153,"twenty":-26.611418,"median":-10.904819,"eighty":-7.041446,"marketCap":492927774},{"date":"2022-08-05","current":-7.124459,"twenty":-26.551575,"median":-10.613193,"eighty":-6.991534,"marketCap":519031093},{"date":"2022-08-12","current":-7.07352,"twenty":-26.496518,"median":-10.361343,"eighty":-6.934474,"marketCap":602932684},{"date":"2022-08-19","current":-7.180586,"twenty":-26.463005,"median":-10.23266,"eighty":-6.94114,"marketCap":612058810},{"date":"2022-08-26","current":-7.301928,"twenty":-26.40241,"median":-10.166322,"eighty":-6.991534,"marketCap":622401752},{"date":"2022-09-02","current":-7.027124,"twenty":-26.300527,"median":-9.98006,"eighty":-6.991534,"marketCap":598978030},{"date":"2022-09-09","current":-8.18701,"twenty":-26.197298,"median":-9.814709,"eighty":-7.025928,"marketCap":697844388},{"date":"2022-09-16","current":-8.115633,"twenty":-26.020483,"median":-9.779887,"eighty":-7.032727,"marketCap":691760305},{"date":"2022-09-23","current":-7.094933,"twenty":-25.624298,"median":-9.581279,"eighty":-7.042667,"marketCap":604757909},{"date":"2022-09-30","current":-7.530336,"twenty":-25.107868,"median":-9.437416,"eighty":-7.042667,"marketCap":641870819},{"date":"2022-10-07","current":-7.251964,"twenty":-24.914243,"median":-9.355894,"eighty":-7.047911,"marketCap":618142893},{"date":"2022-10-14","current":-6.673805,"twenty":-24.832855,"median":-9.129195,"eighty":-7.024186,"marketCap":568861816},{"date":"2022-10-21","current":-6.8808,"twenty":-24.694017,"median":-9.092275,"eighty":-6.93114,"marketCap":586505659},{"date":"2022-10-28","current":-6.973591,"twenty":-24.57133,"median":-8.936475,"eighty":-6.899476,"marketCap":594414967},{"date":"2022-11-04","current":-6.666668,"twenty":-24.498154,"median":-8.852373,"eighty":-6.872007,"marketCap":568253408},{"date":"2022-11-11","current":-6.965012,"twenty":-24.295064,"median":-8.779444,"eighty":-6.840655,"marketCap":633196203},{"date":"2022-11-18","current":-6.092708,"twenty":-24.103187,"median":-8.681852,"eighty":-6.789144,"marketCap":553894173},{"date":"2022-11-25","current":-5.871277,"twenty":-24.017439,"median":-8.59332,"eighty":-6.76782,"marketCap":533763658},{"date":"2022-12-02","current":-6.44834,"twenty":-23.959133,"median":-8.48792,"eighty":-6.746044,"marketCap":586225001},{"date":"2022-12-09","current":-6.018898,"twenty":-23.878854,"median":-8.443599,"eighty":-6.703458,"marketCap":547184002},{"date":"2022-12-16","current":-5.206984,"twenty":-23.772484,"median":-8.357638,"eighty":-6.67616,"marketCap":473372113},{"date":"2022-12-23","current":-4.133379,"twenty":-23.704665,"median":-8.312314,"eighty":-6.655146,"marketCap":375769615},{"date":"2022-12-30","current":-4.213899,"twenty":-23.674276,"median":-8.286993,"eighty":-6.635348,"marketCap":383089803},{"date":"2023-01-06","current":-4.616501,"twenty":-23.243399,"median":-8.203193,"eighty":-6.520104,"marketCap":419690739},{"date":"2023-01-13","current":-4.844642,"twenty":-22.972905,"median":-8.115633,"eighty":-6.439687,"marketCap":440431270},{"date":"2023-01-20","current":-4.28771,"twenty":-22.722748,"median":-8.075513,"eighty":-6.292881,"marketCap":389799974},{"date":"2023-01-27","current":-4.891612,"twenty":-21.758534,"median":-8.050988,"eighty":-6.25353,"marketCap":444701379},{"date":"2023-02-03","current":-5.099623,"twenty":-20.91142,"median":-7.895339,"eighty":-6.155698,"marketCap":463611863},{"date":"2023-02-10","current":-4.549401,"twenty":-20.695995,"median":-7.840829,"eighty":-6.092708,"marketCap":413590583},{"date":"2023-02-17","current":-4.596371,"twenty":-20.58733,"median":-7.673092,"eighty":-6.027284,"marketCap":417860692},{"date":"2023-02-24","current":-3.891818,"twenty":-20.470651,"median":-7.599423,"eighty":-5.925356,"marketCap":353809053},{"date":"2023-03-03","current":-4.099829,"twenty":-20.3494,"median":-7.558853,"eighty":-5.793776,"marketCap":372719537},{"date":"2023-03-10","current":-3.193816,"twenty":-20.238457,"median":-7.530336,"eighty":-5.607908,"marketCap":317532378},{"date":"2023-03-17","current":-3.058171,"twenty":-20.0135,"median":-7.480931,"eighty":-5.537913,"marketCap":304046447},{"date":"2023-03-24","current":-2.854704,"twenty":-19.744696,"median":-7.437546,"eighty":-5.459906,"marketCap":283817550},{"date":"2023-03-31","current":-3.27397,"twenty":-19.639844,"median":-7.432905,"eighty":-5.134515,"marketCap":325501337},{"date":"2023-04-06","current":-3.286301,"twenty":-19.243311,"median":-7.422659,"eighty":-4.986895,"marketCap":326727331},{"date":"2023-04-14","current":-2.990349,"twenty":-17.962203,"median":-7.373306,"eighty":-4.884693,"marketCap":297303481},{"date":"2023-04-21","current":-2.663569,"twenty":-17.897384,"median":-7.298359,"eighty":-4.838605,"marketCap":264814647},{"date":"2023-04-28","current":-2.571084,"twenty":-17.849724,"median":-7.28278,"eighty":-4.761886,"marketCap":255619694},{"date":"2023-05-05","current":-2.714846,"twenty":-17.609516,"median":-7.24279,"eighty":-4.684775,"marketCap":269912667},{"date":"2023-05-12","current":-2.479177,"twenty":-17.167229,"median":-7.198406,"eighty":-4.650051,"marketCap":268685791},{"date":"2023-05-19","current":-2.412038,"twenty":-17.005184,"median":-7.188294,"eighty":-4.616501,"marketCap":261409417},{"date":"2023-05-26","current":-2.460165,"twenty":-16.852671,"median":-7.163245,"eighty":-4.556111,"marketCap":266625332},{"date":"2023-06-02","current":-2.593224,"twenty":-16.852671,"median":-7.132792,"eighty":-4.535981,"marketCap":281045805},{"date":"2023-06-09","current":-2.530941,"twenty":-16.791666,"median":-7.124459,"eighty":-4.506457,"marketCap":274295797},{"date":"2023-06-16","current":-2.604548,"twenty":-16.654405,"median":-7.084226,"eighty":-4.43153,"marketCap":282273079},{"date":"2023-06-23","current":-2.412038,"twenty":-16.41229,"median":-7.070453,"eighty":-4.352126,"marketCap":261409417},{"date":"2023-06-30","current":-2.310121,"twenty":-16.267403,"median":-7.063885,"eighty":-4.295762,"marketCap":250363949},{"date":"2023-07-07","current":-3.62034,"twenty":-16.259778,"median":-7.048647,"eighty":-4.226423,"marketCap":392361615},{"date":"2023-07-14","current":-6.405595,"twenty":-16.229275,"median":-7.027124,"eighty":-4.226423,"marketCap":694219191},{"date":"2023-07-21","current":-5.209464,"twenty":-16.135861,"median":-6.998574,"eighty":-4.254677,"marketCap":564586124},{"date":"2023-07-28","current":-5.020602,"twenty":-16.128235,"median":-6.969302,"eighty":-4.274675,"marketCap":544117744},{"date":"2023-08-04","current":-5.382589,"twenty":-16.099639,"median":-6.94504,"eighty":-4.28771,"marketCap":583348804},{"date":"2023-08-11","current":-5.724271,"twenty":-15.809865,"median":-6.94114,"eighty":-4.303814,"marketCap":636533234},{"date":"2023-08-18","current":-4.858882,"twenty":-15.542967,"median":-6.909351,"eighty":-4.30794,"marketCap":540302829},{"date":"2023-08-25","current":-5.00973,"twenty":-15.224596,"median":-6.895339,"eighty":-4.319984,"marketCap":557076936},{"date":"2023-09-01","current":-4.676277,"twenty":-15.081615,"median":-6.866145,"eighty":-4.352126,"marketCap":519997330},{"date":"2023-09-08","current":-4.596884,"twenty":-15.066364,"median":-6.84948,"eighty":-4.376282,"marketCap":511168853},{"date":"2023-09-13","current":-4.843003,"twenty":-15.060645,"median":-6.822097,"eighty":-4.38836,"marketCap":538537133},{"date":"2023-09-22","current":-4.176098,"twenty":-14.938635,"median":-6.791334,"eighty":-4.327765,"marketCap":464377921},{"date":"2023-09-29","current":-3.755312,"twenty":-14.885255,"median":-6.774486,"eighty":-4.285103,"marketCap":417586990},{"date":"2023-10-05","current":-3.588586,"twenty":-14.713679,"median":-6.757001,"eighty":-4.217925,"marketCap":399047187},{"date":"2023-10-13","current":-3.278951,"twenty":-14.599294,"median":-6.750905,"eighty":-4.172922,"marketCap":364616124},{"date":"2023-10-20","current":-3.120164,"twenty":-14.557353,"median":-6.730907,"eighty":-4.101171,"marketCap":346959169},{"date":"2023-10-27","current":-3.032832,"twenty":-14.503974,"median":-6.72377,"eighty":-4.090435,"marketCap":337247844},{"date":"2023-11-03","current":-2.937559,"twenty":-14.410559,"median":-6.702356,"eighty":-4.044141,"marketCap":326653671},{"date":"2023-11-10","current":-3.689541,"twenty":-14.269484,"median":-6.682826,"eighty":-4.00052,"marketCap":348860831},{"date":"2023-11-17","current":-4.423708,"twenty":-14.021651,"median":-6.670236,"eighty":-3.946239,"marketCap":418279273},{"date":"2023-11-24","current":-5.293486,"twenty":-13.869139,"median":-6.659276,"eighty":-3.956975,"marketCap":500520229},{"date":"2023-12-01","current":-5.489887,"twenty":-13.396348,"median":-6.638074,"eighty":-3.991126,"marketCap":519090768},{"date":"2023-12-08","current":-5.564707,"twenty":-12.624252,"median":-6.620003,"eighty":-4.028036,"marketCap":526165259},{"date":"2023-12-15","current":-5.77046,"twenty":-12.378325,"median":-6.502499,"eighty":-4.043137,"marketCap":545620109},{"date":"2023-12-22","current":-5.77046,"twenty":-12.305882,"median":-6.446868,"eighty":-4.046481,"marketCap":545620109},{"date":"2023-12-29","current":-5.499239,"twenty":-12.248689,"median":-6.416846,"eighty":-4.04698,"marketCap":519975079},{"date":"2024-01-05","current":-4.825863,"twenty":-12.231531,"median":-6.361256,"eighty":-4.054533,"marketCap":456304661},{"date":"2024-01-12","current":-4.956797,"twenty":-12.202035,"median":-6.291189,"eighty":-4.075673,"marketCap":468685020},{"date":"2024-01-19","current":-5.031617,"twenty":-12.133404,"median":-6.273879,"eighty":-4.089093,"marketCap":475759511},{"date":"2024-01-26","current":-5.022265,"twenty":-11.828891,"median":-6.247039,"eighty":-4.095803,"marketCap":474875200},{"date":"2024-02-02","current":-6.256788,"twenty":-11.384363,"median":-6.206778,"eighty":-4.102513,"marketCap":591604299},{"date":"2024-02-09","current":-6.350312,"twenty":-11.173363,"median":-6.247039,"eighty":-4.117275,"marketCap":600447413},{"date":"2024-02-16","current":-6.546714,"twenty":-11.103802,"median":-6.256788,"eighty":-4.146799,"marketCap":619017952},{"date":"2024-02-23","current":-6.471894,"twenty":-11.081966,"median":-6.273879,"eighty":-4.167969,"marketCap":611943461},{"date":"2024-03-01","current":-7.397786,"twenty":-11.034336,"median":-6.292599,"eighty":-4.172922,"marketCap":699490285},{"date":"2024-03-08","current":-6.920811,"twenty":-10.883819,"median":-6.316917,"eighty":-4.183658,"marketCap":654390406},{"date":"2024-03-15","current":-4.742684,"twenty":-10.767109,"median":-6.305557,"eighty":-4.215241,"marketCap":484085725},{"date":"2024-03-22","current":-4.645353,"twenty":-10.627042,"median":-6.291189,"eighty":-4.223819,"marketCap":474151130},{"date":"2024-03-28","current":-4.530325,"twenty":-10.590112,"median":-6.273879,"eighty":-4.236659,"marketCap":462410245},{"date":"2024-04-05","current":-4.017124,"twenty":-10.559548,"median":-6.251914,"eighty":-4.220609,"marketCap":410027834},{"date":"2024-04-12","current":-3.83131,"twenty":-10.361343,"median":-6.206778,"eighty":-4.166929,"marketCap":391061789},{"date":"2024-04-19","current":-3.459682,"twenty":-10.271822,"median":-6.14796,"eighty":-4.099829,"marketCap":353129698},{"date":"2024-04-26","current":-3.327078,"twenty":-10.237426,"median":-6.097796,"eighty":-4.04698,"marketCap":339594818},{"date":"2024-05-03","current":-3.220894,"twenty":-10.227894,"median":-6.083623,"eighty":-4.017124,"marketCap":328756686},{"date":"2024-05-10","current":-2.860141,"twenty":-10.180234,"median":-6.051034,"eighty":-3.946338,"marketCap":329659864},{"date":"2024-05-17","current":-2.813125,"twenty":-10.166322,"median":-5.998767,"eighty":-3.898221,"marketCap":324240797},{"date":"2024-05-24","current":-2.358637,"twenty":-10.142105,"median":-5.898117,"eighty":-3.849006,"marketCap":271856490},{"date":"2024-05-31","current":-2.256769,"twenty":-10.012469,"median":-5.871277,"eighty":-3.793421,"marketCap":260115180},{"date":"2024-06-07","current":-1.528021,"twenty":-9.98006,"median":-5.796496,"eighty":-3.7221,"marketCap":176119653},{"date":"2024-06-14","current":-1.402645,"twenty":-9.85805,"median":-5.77046,"eighty":-3.617165,"marketCap":161668810},{"date":"2024-06-21","current":-1.347793,"twenty":-9.812141,"median":-5.761108,"eighty":-3.599025,"marketCap":155346566},{"date":"2024-06-28","current":-1.285104,"twenty":-9.794399,"median":-5.731708,"eighty":-3.538934,"marketCap":148121144},{"date":"2024-07-05","current":-1.25376,"twenty":-9.785606,"median":-5.709956,"eighty":-3.473135,"marketCap":144508433},{"date":"2024-07-12","current":-1.582873,"twenty":-9.707443,"median":-5.676936,"eighty":-3.406592,"marketCap":182441897},{"date":"2024-07-19","current":-1.798363,"twenty":-9.595615,"median":-5.632906,"eighty":-3.379179,"marketCap":207279284},{"date":"2024-07-26","current":-1.951165,"twenty":-9.583197,"median":-5.602116,"eighty":-3.326784,"marketCap":224891249},{"date":"2024-08-02","current":-1.669069,"twenty":-9.529488,"median":-5.574318,"eighty":-3.284221,"marketCap":192376852},{"date":"2024-08-09","current":-1.420177,"twenty":-9.45468,"median":-5.564707,"eighty":-3.26867,"marketCap":175303775},{"date":"2024-08-16","current":-1.529984,"twenty":-9.410562,"median":-5.555534,"eighty":-3.215745,"marketCap":188858191},{"date":"2024-08-23","current":-1.61783,"twenty":-9.366444,"median":-5.524581,"eighty":-3.190116,"marketCap":199701723},{"date":"2024-08-30","current":-1.581228,"twenty":-9.356853,"median":-5.499239,"eighty":-3.112564,"marketCap":195183585},{"date":"2024-09-06","current":-1.259126,"twenty":-9.30698,"median":-5.491959,"eighty":-3.0379,"marketCap":155423966},{"date":"2024-09-13","current":-1.551946,"twenty":-9.130245,"median":-5.475385,"eighty":-2.969385,"marketCap":191569074},{"date":"2024-09-20","current":-1.515343,"twenty":-9.124912,"median":-5.44363,"eighty":-2.917655,"marketCap":187050935},{"date":"2024-09-27","current":-1.449459,"twenty":-9.106572,"median":-5.433772,"eighty":-2.883927,"marketCap":178918286},{"date":"2024-10-04","current":-1.368933,"twenty":-9.097951,"median":-5.380123,"eighty":-2.852785,"marketCap":168978381},{"date":"2024-10-11","current":-1.390895,"twenty":-9.059743,"median":-5.368305,"eighty":-2.818943,"marketCap":171689264},{"date":"2024-10-18","current":-1.4641,"twenty":-8.961265,"median":-5.333776,"eighty":-2.769787,"marketCap":180725542},{"date":"2024-10-25","current":-1.295728,"twenty":-8.931164,"median":-5.302838,"eighty":-2.740141,"marketCap":159942104},{"date":"2024-11-01","current":-1.61783,"twenty":-8.900327,"median":-5.288809,"eighty":-2.71608,"marketCap":199701723},{"date":"2024-11-08","current":-1.638409,"twenty":-8.858128,"median":-5.233072,"eighty":-2.706465,"marketCap":242681201},{"date":"2024-11-15","current":-1.21658,"twenty":-8.837028,"median":-5.209464,"eighty":-2.672504,"marketCap":180199847},{"date":"2024-11-22","current":-1.234921,"twenty":-8.807097,"median":-5.206984,"eighty":-2.657185,"marketCap":182916427},{"date":"2024-11-29","current":-1.338849,"twenty":-8.779444,"median":-5.186854,"eighty":-2.651237,"marketCap":198310384},{"date":"2024-12-06","current":-1.302169,"twenty":-8.702096,"median":-5.138278,"eighty":-2.604548,"marketCap":192877223},{"date":"2024-12-13","current":-1.167672,"twenty":-8.683967,"median":-5.099623,"eighty":-2.571084,"marketCap":172955632},{"date":"2024-12-20","current":-1.100424,"twenty":-8.679737,"median":-5.077215,"eighty":-2.494138,"marketCap":162994836},{"date":"2024-12-27","current":-1.020949,"twenty":-8.632359,"median":-5.026941,"eighty":-2.459599,"marketCap":151222987},{"date":"2025-01-03","current":-1.051516,"twenty":-8.587881,"median":-5.018252,"eighty":-2.455468,"marketCap":155750621},{"date":"2025-01-10","current":-1.002609,"twenty":-8.565534,"median":-5.011321,"eighty":-2.432213,"marketCap":148506406},{"date":"2025-01-17","current":-0.935361,"twenty":-8.533956,"median":-5.005683,"eighty":-2.408641,"marketCap":138545611},{"date":"2025-01-24","current":-0.923134,"twenty":-8.487695,"median":-4.985553,"eighty":-2.359125,"marketCap":136734557},{"date":"2025-01-31","current":-0.874226,"twenty":-8.48272,"median":-4.95987,"eighty":-2.310121,"marketCap":129490342},{"date":"2025-02-07","current":-0.825318,"twenty":-8.457288,"median":-4.956797,"eighty":-2.292002,"marketCap":122246127},{"date":"2025-02-14","current":-0.825318,"twenty":-8.413594,"median":-4.952411,"eighty":-2.158035,"marketCap":122246127},{"date":"2025-02-21","current":-0.800864,"twenty":-8.384832,"median":-4.935075,"eighty":-1.911985,"marketCap":118624019},{"date":"2025-02-28","current":-0.715276,"twenty":-8.357638,"median":-4.907961,"eighty":-1.849297,"marketCap":105946643},{"date":"2025-03-07","current":-0.709162,"twenty":-8.357638,"median":-4.887288,"eighty":-1.798363,"marketCap":105041116},{"date":"2025-03-14","current":-0.62999,"twenty":-8.321379,"median":-4.872625,"eighty":-1.705658,"marketCap":93934648},{"date":"2025-03-21","current":-0.648702,"twenty":-8.30325,"median":-4.861078,"eighty":-1.680823,"marketCap":96724786},{"date":"2025-03-28","current":-0.585766,"twenty":-8.294185,"median":-4.848863,"eighty":-1.638409,"marketCap":87340621},{"date":"2025-04-04","current":-0.47873,"twenty":-8.279801,"median":-4.843822,"eighty":-1.61783,"marketCap":71381032},{"date":"2025-04-11","current":-0.545347,"twenty":-8.219376,"median":-4.837932,"eighty":-1.581228,"marketCap":81313923},{"date":"2025-04-17","current":-0.458458,"twenty":-8.193483,"median":-4.832966,"eighty":-1.550482,"marketCap":68358382},{"date":"2025-04-25","current":-0.482784,"twenty":-8.130242,"median":-4.807158,"eighty":-1.531548,"marketCap":71985561},{"date":"2025-05-02","current":-0.548902,"twenty":-8.115716,"median":-4.777542,"eighty":-1.52695,"marketCap":81844049},{"date":"2025-05-09","current":-0.487032,"twenty":-8.098502,"median":-4.760791,"eighty":-1.515343,"marketCap":72013463},{"date":"2025-05-16","current":-0.59025,"twenty":-8.079254,"median":-4.742684,"eighty":-1.491918,"marketCap":87275518},{"date":"2025-05-23","current":-0.688751,"twenty":-8.061927,"median":-4.723377,"eighty":-1.473169,"marketCap":101840039},{"date":"2025-05-30","current":-0.729635,"twenty":-8.058046,"median":-4.701624,"eighty":-1.458244,"marketCap":107885338},{"date":"2025-06-06","current":-0.685606,"twenty":-8.049642,"median":-4.676891,"eighty":-1.44619,"marketCap":101375016},{"date":"2025-06-13","current":-0.729635,"twenty":-7.984298,"median":-4.66255,"eighty":-1.434818,"marketCap":107885338},{"date":"2025-06-20","current":-0.805115,"twenty":-7.924732,"median":-4.65461,"eighty":-1.428961,"marketCap":119045890},{"date":"2025-06-27","current":-0.849145,"twenty":-7.880673,"median":-4.645353,"eighty":-1.415784,"marketCap":125556212},{"date":"2025-07-03","current":-0.861724,"twenty":-7.857246,"median":-4.629921,"eighty":-1.403223,"marketCap":127416304},{"date":"2025-07-11","current":-1.094453,"twenty":-7.847253,"median":-4.62394,"eighty":-1.390895,"marketCap":161828007},{"date":"2025-07-18","current":-1.151063,"twenty":-7.822984,"median":-4.599651,"eighty":-1.383574,"marketCap":170198421},{"date":"2025-07-25","current":-1.49072,"twenty":-7.780572,"median":-4.584718,"eighty":-1.380024,"marketCap":220420906},{"date":"2025-08-01","current":-1.276862,"twenty":-7.714716,"median":-4.556111,"eighty":-1.372292,"marketCap":188799342},{"date":"2025-08-08","current":-1.138483,"twenty":-7.665954,"median":-4.548711,"eighty":-1.354292,"marketCap":168338329},{"date":"2025-08-15","current":-1.133831,"twenty":-7.629807,"median":-4.535981,"eighty":-1.344963,"marketCap":186246478},{"date":"2025-08-22","current":-1.043124,"twenty":-7.592743,"median":-4.520253,"eighty":-1.333635,"marketCap":171346759},{"date":"2025-08-29","current":-1.099816,"twenty":-7.564809,"median":-4.50788,"eighty":-1.322038,"marketCap":180659083},{"date":"2025-09-05","current":-1.048794,"twenty":-7.559946,"median":-4.468881,"eighty":-1.310369,"marketCap":172277992},{"date":"2025-09-12","current":-1.082809,"twenty":-7.55776,"median":-4.458289,"eighty":-1.302022,"marketCap":177865386},{"date":"2025-09-19","current":-1.00911,"twenty":-7.541817,"median":-4.441842,"eighty":-1.289442,"marketCap":165759365},{"date":"2025-09-26","current":-1.094147,"twenty":-7.530336,"median":-4.424284,"eighty":-1.277715,"marketCap":179727851},{"date":"2025-10-03","current":-1.264222,"twenty":-7.519368,"median":-4.38836,"eighty":-1.276862,"marketCap":207664822},{"date":"2025-10-10","current":-1.559018,"twenty":-7.508923,"median":-4.347781,"eighty":-1.277715,"marketCap":256088907},{"date":"2025-10-17","current":-1.513664,"twenty":-7.487429,"median":-4.308006,"eighty":-1.281229,"marketCap":248639048},{"date":"2025-10-24","current":-1.417289,"twenty":-7.474433,"median":-4.281192,"eighty":-1.283152,"marketCap":232808097},{"date":"2025-10-31","current":-1.315244,"twenty":-7.466097,"median":-4.236659,"eighty":-1.285104,"marketCap":216045914},{"date":"2025-11-07","current":-1.213199,"twenty":-7.437546,"median":-4.217254,"eighty":-1.281229,"marketCap":199283731},{"date":"2025-11-14","current":-1.125327,"twenty":-7.43304,"median":-4.172128,"eighty":-1.269891,"marketCap":184849629},{"date":"2025-11-21","current":-1.040999,"twenty":-7.43304,"median":-4.137189,"eighty":-1.259126,"marketCap":163569066},{"date":"2025-11-28","current":-1.154022,"twenty":-7.432823,"median":-4.103184,"eighty":-1.252193,"marketCap":181327993},{"date":"2025-12-05","current":-1.154022,"twenty":-7.43088,"median":-4.086409,"eighty":-1.239811,"marketCap":181327993},{"date":"2025-12-12","current":-1.106433,"twenty":-7.41801,"median":-4.046564,"eighty":-1.234503,"marketCap":173850550},{"date":"2025-12-19","current":-0.969616,"twenty":-7.401211,"median":-4.019308,"eighty":-1.221249,"marketCap":152352901},{"date":"2025-12-26","current":-1.023153,"twenty":-7.386306,"median":-3.981731,"eighty":-1.212106,"marketCap":160765025},{"date":"2026-01-02","current":-0.945822,"twenty":-7.376514,"median":-3.946733,"eighty":-1.20753,"marketCap":148614180},{"date":"2026-01-09","current":-1.005308,"twenty":-7.361886,"median":-3.942143,"eighty":-1.186013,"marketCap":157960984},{"date":"2026-01-16","current":-0.927976,"twenty":-7.327624,"median":-3.898221,"eighty":-1.177114,"marketCap":145810139},{"date":"2026-01-23","current":-0.963668,"twenty":-7.3005,"median":-3.891818,"eighty":-1.156752,"marketCap":151418221},{"date":"2026-01-30","current":-0.880388,"twenty":-7.293363,"median":-3.840158,"eighty":-1.151063,"marketCap":138332696},{"date":"2026-02-06","current":-0.880388,"twenty":-7.287234,"median":-3.795009,"eighty":-1.134761,"marketCap":138332696},{"date":"2026-02-13","current":-0.904182,"twenty":-7.285002,"median":-3.746399,"eighty":-1.126307,"marketCap":142071417},{"date":"2026-02-20","current":-1.046948,"twenty":-7.28278,"median":-3.719919,"eighty":-1.122493,"marketCap":164503746},{"date":"2026-02-27","current":-1.183765,"twenty":-7.266115,"median":-3.675919,"eighty":-1.122493,"marketCap":186001395},{"date":"2026-03-06","current":-1.017205,"twenty":-7.251964,"median":-3.60286,"eighty":-1.112382,"marketCap":159830344},{"date":"2026-03-13","current":-1.233042,"twenty":-7.233617,"median":-3.596525,"eighty":-1.112382,"marketCap":182644311},{"date":"2026-03-20","current":-1.285234,"twenty":-7.199453,"median":-3.546371,"eighty":-1.122493,"marketCap":190375287},{"date":"2026-03-27","current":-1.24609,"twenty":-7.197359,"median":-3.52162,"eighty":-1.122493,"marketCap":184577055},{"date":"2026-04-02","current":-1.298282,"twenty":-7.190107,"median":-3.459682,"eighty":-1.122493,"marketCap":192308031},{"date":"2026-04-10","current":-1.27871,"twenty":-7.188294,"median":-3.422165,"eighty":-1.123922,"marketCap":189408915}],"updateTime":1776011476880},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRBU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581729315","title":"Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2581729315","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581729315?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:50","pubTimestamp":1762343400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRBU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 05, 2025 06:50 ET (11:50 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580229974","title":"Caribou Biosciences to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2580229974","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580229974?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:15","pubTimestamp":1762208100,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif., Nov.  03, 2025  (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management wil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179891/0/en/Caribou-Biosciences-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","CRSP","BK4588","BK4139","BK4556","BK4539","BK4611","LU1861558580.USD","BK4585","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580924345","title":"Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>","url":"https://stock-news.laohu8.com/highlight/detail?id=2580924345","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580924345?lang=en_us&edition=fundamental","pubTime":"2025-11-04 00:48","pubTimestamp":1762188480,"startTime":"0","endTime":"0","summary":"Caribou Biosciences Inc.  stock surged on Monday. The company said the CAR-T therapy induced complete and durable remissions in patients with advanced B-cell lymphoma.The CRISPR genome-editing biopharmaceutical company shared preliminary results from its ongoing ANTLER phase 1 trial of vispacabtagene regedleucel , an allogeneic anti-CD19 CAR-T cell therapy, for relapsed or refractory B-cell non-Hodgkin lymphoma.The cell therapy uses T-cells from a healthy donor, rather than the patient's own cells, to fight cancer.Also Read: FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering. In the study, 64% of patients treated with Caribou's therapy achieved a complete response. The overall response rate was 82%.In recent interactions, the FDA has recommended that the company conduct a randomized, controlled trial in second-line  large B-cell lymphoma  CD19-naive patients who are ineligible for transplant and autologous CAR-T cell therapy.The company is advancin","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/03/Gene-editing.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/03/Gene-editing.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/fda/25/11/48596655/why-is-crispr-genome-editing-firm-caribou-biosciences-stock-trading-higher-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/11/48596655/why-is-crispr-genome-editing-firm-caribou-biosciences-stock-trading-higher-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU1861559042.SGD","CRSP","BK4139","BK4022","BK4588","BK4556","BK4539","BK4611","LU1861558580.USD","CAR","BK4585","BK4230","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580217319","title":"Caribou Biosciences Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2580217319","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580217319?lang=en_us&edition=fundamental","pubTime":"2025-11-03 23:27","pubTimestamp":1762183620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRBU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 03, 2025 10:27 ET (15:27 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580212230","title":"ADVISORY-Alert inadvertently tagged to Caribou Biosciences withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2580212230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580212230?lang=en_us&edition=fundamental","pubTime":"2025-11-03 23:17","pubTimestamp":1762183065,"startTime":"0","endTime":"0","summary":"ADVISORY-Alert inadvertently tagged to Caribou Biosciences withdrawnNov 3 (Reuters) - An alert on auto refinance platform Caribou launching a resource for daily rates was inadvertently tagged to Carib","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA5NY1RH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580229212","title":"Caribou Biosciences price target raised to $8 from $5 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2580229212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580229212?lang=en_us&edition=fundamental","pubTime":"2025-11-03 23:15","pubTimestamp":1762182934,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Caribou Biosciences (CRBU) to $8 from $5 and keeps a Buy rating on the shares, citing “meaningfully increase...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caribou-biosciences-price-target-raised-to-8-from-5-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caribou-biosciences-price-target-raised-to-8-from-5-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580219209","title":"Caribou Shares Surge On Positive Data From Two Drug Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2580219209","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580219209?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:17","pubTimestamp":1762179420,"startTime":"0","endTime":"0","summary":"Shares of Caribou Biosciences surged after the company released positive data from studies  of its treatment of Multiple Myeloma and its treatment of non-Hodgkin lymphoma.The stock rose 46% to $3.52 in premarket trading after closing Friday up 52% this year.Caribou said its treatment of Multiple Myeloma, called CB-011, delivered meaningful and durable responses and had a manageable safety profile in a phase 1 trial.The company will begin dose expansion by the end of the year and share dose expansion data in 2026.Caribou also said Monday that its phase one trial of its treatment for non-Hodgkin lymphoma, called Vispa-cel, demonstrated efficacy and durability and a well-tolerated safety profile.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580118216","title":"Caribou Launches \"Today's Auto Refinance Rates\", First-Ever Daily Rates Resource Bringing Unmatched Transparency to What Lenders Are Actually Offering Borrowers","url":"https://stock-news.laohu8.com/highlight/detail?id=2580118216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580118216?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:46","pubTimestamp":1762177594,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA5NY1RH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBU","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580135452","title":"Caribou Says Potential Non-Hodgkin Lymphoma Therapy Shows High Overall Response; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2580135452","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580135452?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:01","pubTimestamp":1762174879,"startTime":"0","endTime":"0","summary":"Caribou Biosciences  said Monday that an ongoing phase 1 clinical trial of its \"off-the-shelf\" cell therapy vispacabtagene regedleucel in patients with relapsed or refractory B cell non-Hodgkin lymphoma is showing both \"efficacy and durability\" comparable to other therapies.The 84-patient study showed an 82% overall response rate, a 64% complete response rate, and a 51% progression-free survival rate at 12 months, the company said.The company also said that a phase 1 trial evaluating CB-011, an \"off-the-shelf\" cell therapy, in relapsed or refractory multiple myeloma is advancing into dose expansion, which is expected to begin by the end of this year.As of Sept. 24, the 12-patient cohort in the study treated with the cell therapy showed a 92% overall response rate and a 75% complete response rate, the company said.Shares of the company were up more than 39% in recent premarket activity Monday.Price: 3.97, Change: +0.96, Percent Change: +39.67","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580218672","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2580218672","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580218672?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:43","pubTimestamp":1762173810,"startTime":"0","endTime":"0","summary":"Caribou Biosciences  shares were 40% higher pre-bell Monday after the company said its phase 1 trial of a treatment candidate for multiple myeloma showed an overall response rate of 92%.Currenc Group  stock was up 34% after the company said it has offered to acquire Animoca Brands through a reverse merger.IREN  shares were 22% higher after the company said it has secured a $9.70 billion GPU cloud services contract from Microsoft  and a $5.80 billion deal with Dell Technologies  to purchase GPUs and related equipment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0011850046.USD","BK4538","LU0466842654.USD","LU2592432038.USD","LU1670710588.SGD","LU2065170008.USD","LU0342679015.USD","LU0097036916.USD","BK4023","DELL","LU2362541273.HKD","IE0009G5SDU7.USD","LU0302445910.USD","CRBU","IE000ITXATA3.USD","LU2491050154.USD","LU2357305700.SGD","BK4097","GB00BDT5M118.USD","LU0310799852.SGD","LU0528227936.USD","LU1366333091.USD","LU1697837992.HKD","IE0034235188.USD","LU2237443978.SGD","BK4533","LU1988902786.USD","LU2237443622.USD","LU2237443549.SGD","LU1582987597.SGD","LU2491050071.SGD","IE00B1XK9C88.USD","SGXZ23171101.USD","LU1642822529.SGD","LU2491049909.HKD","LU0171293334.USD","IE000YTNTUN2.SGD","BK4535","CURR","LU1670711123.USD","LU2461242641.AUD","LU1670710661.SGD","LU1582987324.SGD","LU2362541513.USD","LU1280957306.USD","LU2089284900.SGD","LU0109391861.USD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2580921857","title":"BRIEF-Caribou Biosciences Expects Cash And Marketable Securities As Of Sept 30 To Be $159.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2580921857","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580921857?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:40","pubTimestamp":1762173625,"startTime":"0","endTime":"0","summary":"BRIEF-Caribou Biosciences Expects Cash And Marketable Securities As Of Sept 30 To Be $159.2 Million Nov 3  - Caribou Biosciences Inc CRBU.O:CARIBOU BIOSCIENCES INC - EXPECTS CASH AND MARKETABLE SECURITIES AS OF SEPT 30, 2025 TO BE $159.2 MILLION - SEC FILINGSource text: [ID:n0001619856-25-000065]Further company coverage: CRBU.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WF0DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580290629","title":"Caribou Biosciences announces results from ANTLER phase 1 trial of vispa-cel","url":"https://stock-news.laohu8.com/highlight/detail?id=2580290629","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580290629?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:15","pubTimestamp":1762172112,"startTime":"0","endTime":"0","summary":"Caribou Biosciences (CRBU) announced positive results from its ongoing ANTLER phase 1 clinical trial evaluating vispacabtagene regedleucel, vispa-c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caribou-biosciences-announces-results-from-antler-phase-1-trial-of-vispa-cel-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caribou-biosciences-announces-results-from-antler-phase-1-trial-of-vispa-cel-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580629749","title":"Caribou Biosciences Inc - Expects Cash and Marketable Securities as of Sept 30, 2025 to Be $159.2 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2580629749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580629749?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:06","pubTimestamp":1762171606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WF0DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBU","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580297504","title":"Caribou Biosciences Announces Positive Phase 1 Results for Vispa-cel in Relapsed or Refractory B Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297504","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297504?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:01","pubTimestamp":1762171262,"startTime":"0","endTime":"0","summary":"Caribou Biosciences, Inc. announced positive results from its ongoing ANTLER phase 1 clinical trial evaluating vispacabtagene regedleucel , an allogeneic anti-CD19 CAR-T cell therapy, in patients with relapsed or refractory B cell non-Hodgkin lymphoma. The company also provided details about the design of its pivotal phase 3 clinical trial for vispa-cel, which will include secondary endpoints such as overall response rate, complete response rate, duration of response, duration of complete response, overall survival, quality of life, and safety. The results from the ANTLER trial and the phase 3 trial design were presented during a webcast and conference call on November 3, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caribou Bio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDLbrdVPm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0314104364.USD","IE00BGHQF748.EUR","BK4539","LU2210150020.SGD","NDAQ","BK4588","LU2095319765.USD","BK4585","LU2210149790.SGD","IE00BKPKM429.USD","CRBU","BK4112","IE00B64PRP62.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580297659","title":"Caribou Biosciences Inc - Vispa-Cel Well-Tolerated for Outpatient Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297659?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA1GWRWH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBU","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580297387","title":"Caribou Biosciences Announces Positive Data From Antler Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-Cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par With Autologous CAR-T Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297387?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171205,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA1GWRWH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBU","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580975992","title":"Caribou Biosciences Inc - 450 Mln Cell Dose Recommended for Expansion; Dose Expansion to Initiate by Year End, Data Expected 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2580975992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580975992?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA5YPPY7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","CRBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580429782","title":"Caribou Biosciences Announces Positive Data From Cammouflage Phase 1 Trial of CB-011 in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2580429782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580429782?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA5YPPY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580297654","title":"Caribou Biosciences Inc - CB-011 Shows Manageable Safety Profile With No Gvhd Cases","url":"https://stock-news.laohu8.com/highlight/detail?id=2580297654","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580297654?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA5YPPY7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CRBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580290236","title":"Caribou Biosciences Announces New Data from Phase 1 CAR-T Trials in Lymphoma and Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2580290236","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580290236?lang=en_us&edition=fundamental","pubTime":"2025-11-03 05:00","pubTimestamp":1762117215,"startTime":"0","endTime":"0","summary":"Caribou Biosciences Inc. has announced it will host a webcast on November 3, 2025, to present new data from two of its allogeneic CAR-T cell therapy programs. The company will report updates from the ANTLER phase 1 clinical trial evaluating vispacabtagene regedleucel  in patients with relapsed or refractory B cell non-Hodgkin lymphoma, as well as the first clinical data from the CaMMouflage Phase 1 trial of CB-011 in patients with relapsed or refractory multiple myeloma. Additionally, Caribou will discuss its anticipated pivotal phase 3 trial design for vispa-cel and outline next steps for the clinical development of CB-011. The results have not yet been presented and will be disclosed during the upcoming webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nNDL9jLQ9W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","IE00B3QW5Z07.USD","CRBU","BK4112","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","BK4588","LU2095319765.USD","LU2210149790.SGD","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":62,"code":"91000000","status":"200"}]}}